Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RMX Biopharma
Shanghai, Chinahaihepharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
RMX Biopharma was a clinical-stage biotech focusing on innovative drugs in infectious diseases, oncology, and CNS/pain before merging into Haihe Biopharma.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
LigaChem BiosciencesAskAt Inc.Daehwa PharmaceuticalPharmaEngine3D MedicinesCSPC
Beyond the preview
Go deeper on RMX Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RMX Biopharma.